Osteogenic potential of bone marrow stromal cells derived from streptozotocin-induced diabetic rats

International Journal of Molecular Medicine

Volumn 31, Issue 3, 2013, Pages 614-620

  Zhao, Yan Fang ^a   Zeng, De Liang ^a   Xia, Lun Guo ^a   Zhang, Song Mei ^a   Xu, Lian Yi ^a   Jiang, Xin Quan ^a   Zhang, Fu Qiang ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow stromal cells; Diabetes mellitus; Insulin; Insulin like growth factor 1; Osteogenesis; Tissue engineering

Indexed keywords

ALIZARIN; ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; EOSIN; HEMATOXYLIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE DISEASE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STROMA CELL;

EID: 84873195651     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1227     Document Type: Article

References (32)

1. Hofbauer LC, Brueck CC, Singh SK and Dobnig H: Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 22: 1317-1328, 2007.
2. Janghorbani M, Van Dam RM, Willett WC and Hu FB: Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166: 495-505, 2007.
3. Retzepi M and Donos N: The effect of diabetes mellitus on osseous healing. Clin Oral Implants Res 21: 673-681, 2010.
4. Yaturu S: Diabetes and skeletal health. J Diabetes 1: 246-254, 2009.
5. Khosla S, Westendorf JJ and Mödder UI: Concise review: Insights from normal bone remodeling and stem cell-based therapies for bone repair. Stem Cells 28: 2124-2128, 2010.
6. Mauney JR, Volloch V and Kaplan DL: Role of adult mesenchymal stem cells in bone tissue engineering applications: current status and future prospects. Tissue Eng 11: 787-802, 2005.
7. Breitbart EA, Meade S, Azad V, et al: Mesenchymal stem cells accelerate bone allograft incorporation in the presence of diabetes mellitus. J Orthop Res 28: 942-949, 2010.
8. Cramer C, Freisinger E, Jones RK, et al: Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev 19: 1875-1884, 2010.
9. Khan M, Akhtar S, Mohsin S, N Khan S and Riazuddin S: Growth factor preconditioning increases the function of diabetes-impaired mesenchymal stem cells. Stem Cells Dev 20: 67-75, 2011.
10. Jin P, Zhang X, Wu Y, et al: Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal cells have impaired abilities in proliferation, paracrine, antiapotosis, and myogenic differentiation. Transplant Proc 42: 2745-2752, 2010.
11. Stolzing A, Sellers D, Llewelyn O and Scutt A: Diabetes induced changes in rat mesenchymal stem cells. Cells Tissues Organs 191: 453-465, 2010.
12. Fulzele K and Clemens TL: Novel functions for insulin in bone. Bone 50: 452-456, 2012.
13. AboElAsrar MA, Elbarbary NS, Elshennawy DE and Omar AM: Iusulin-like growth factor-1 cytokines cross-talk in type 1 diabetes mellitus: relationship to microvascular complications and bone mineral density. Cytokine 59: 86-93, 2012.
14. Gandhi A, Beam HA, O'Connor JP, Parsons JR and Lin SS: The effects of local insulin delivery on diabetic fracture healing. Bone 37: 482-490, 2005.
15. Thaller SR, Lee TJ, Armstrong M, Tesluk H and Stern JS: Effect of insulin-like growth factor type 1 on critical-size defects in diabetic rats. J Craniofac Surg 6: 218-223, 1995.
16. Taniguchi CM, Emanuelli B and Kahn CR: Critical nodes in signaling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7: 85-96, 2006.
17. Zhang W, Shen X, Wan C, Zhao Q, Zhang L, Zhou Q and Deng L: Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK. Cell Biochem Funct 30: 297-302, 2012.
18. Yang J, Zhang X, Wang W and Liu J: Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG-63 cells: cell biochemistry and function. Cell Biochem Funct 28: 334-341, 2010.
19. Fulzele K, Riddle RC, DiGirolamo DJ, et al: Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142: 309-319, 2010.
20. Zhang M, Xuan S, Bouxsein ML, et al: Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277: 44005-44012, 2002.
21. Xian L, Wu X, Pang L, Lou M, et al: Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med 18: 1095-1101, 2012.
22. Retzepi M, Lewis MP and Donos N: Effect of diabetes and metabolic control on de novo bone formation following guided bone regeneration. Clin Oral Implants Res 21: 71-79, 2010.
23. Jiang X, Zhao J, Wang S, et al: Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs. Biomaterials 30: 4522-4532, 2009.
24. Zeng D, Xia L, Zhang W, et al: Maxillary sinus floor elevation using a tissue-engineered bone with calcium-magnesium phosphate cement and bone marrow stromal cells in rabbits. Tissue Eng Part A 18: 870-881, 2012.
25. Lü K, Zeng D, Zhang Y, et al: BMP-2 gene modified canine bMSCs promote ectopic bone formation mediated by a nonviral PEI derivative. Ann Biomed Eng 39: 1829-1839, 2011.
26. Wang XJ, Huang H, Yang F, Xia LG, Zhang WJ, Jiang XQ and Zhang FQ: Ectopic study of tissue-engineered bone complex with enamel matrix proteins, bone marrow stromal cells in porous calcium phosphate cement scaffolds, in nude mice. Cell Prolif 44: 274-282, 2011.
27. Xia L, Xu Y, Chang Q, et al: Maxillary sinus floor elevation using BMP-2 and Nell-1 gene-modified bone marrow stromal cells and TCP in rabbits. Calcif Tissue Int 89: 53-64, 2011.
28. McCabe LR: Understanding the pathology and mechanisms of type 1 diabetic bone loss. J Cell Biochem 102: 1343-1357, 2007.
29. Hie M, Iitsuka N, Otsuka T and Tsukamoto I: Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int J Mol Med 28: 455-462, 2011.
30. Ogata N, Chikazu D, Kubota N, et al: Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 105: 935-943, 2000.
31. Stokoe D, Macdonald SG, Cadwallader K, Symons M and Hancock JF: Activation of Raf as a result of recruitment to the plasma membrane. Science 264: 1463-1467, 1994.
32. Ge C, Yang Q, Zhao G, Yu H, Kirkwood KL and Franceschi RT: Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity. J Bone Miner Res 27: 538-551, 2012.